Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 3Renal Insufficiency, Chronic 2Prostatic Neoplasms 2Uterine Prolapse 1Urologic Neoplasms 1Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Neutropenia 1Neuromuscular Blockade 1Muscle Hypotonia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Melanoma 1Lung Neoplasms 1Leiomyoma 1Intraabdominal Infections 1Intestinal Obstruction 1

Interventions

remimazolam 1Sugammadex 1Rocuronium 1Remifentanil 1Propofol 1Oxycodone 1Flumazenil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endobronchial Metastases × Rocuronium × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡